Chloroquine phosphate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for chloroquine phosphate and what is the scope of patent protection?
Chloroquine phosphate
is the generic ingredient in three branded drugs marketed by Sanofi Aventis Us, Hikma Pharms, Impax Labs, Ipca Labs Ltd, Md Pharm, Natco Pharma Ltd, Purepac Pharm, Suven Pharms, Teva, and Watson Labs, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.There are two drug master file entries for chloroquine phosphate. Eight suppliers are listed for this compound.
Summary for chloroquine phosphate
| US Patents: | 0 |
| Tradenames: | 3 |
| Applicants: | 10 |
| NDAs: | 15 |
| Drug Master File Entries: | 2 |
| Finished Product Suppliers / Packagers: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 109 |
| Clinical Trials: | 48 |
| Patent Applications: | 2,032 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in chloroquine phosphate? | chloroquine phosphate excipients list |
| DailyMed Link: | chloroquine phosphate at DailyMed |
Recent Clinical Trials for chloroquine phosphate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Pan American Health Organization | Phase 2/Phase 3 |
| University of California, San Francisco | Phase 2/Phase 3 |
| Iterum Therapeutics, International Limited | Phase 3 |
Pharmacology for chloroquine phosphate
| Drug Class | Antimalarial |
Anatomical Therapeutic Chemical (ATC) Classes for chloroquine phosphate
US Patents and Regulatory Information for chloroquine phosphate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Md Pharm | CHLOROQUINE PHOSPHATE | chloroquine phosphate | TABLET;ORAL | 087228-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Sanofi Aventis Us | ARALEN | chloroquine phosphate | TABLET;ORAL | 006002-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Watson Labs | CHLOROQUINE PHOSPHATE | chloroquine phosphate | TABLET;ORAL | 088030-001 | Dec 21, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
